Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21775,193,0.86 [0.63-1.17],0.3367555269479495
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22978,252,1.24 [0.95-1.61],0.1094856466885453
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22698,1739,1.07 [0.97-1.18],0.1980916608522354
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Candidiasis,22981,543,1.18 [0.98-1.41],0.0761819088609068
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22225,4199,1.10 [1.03-1.18],0.0036240976804881
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22171,4291,1.14 [1.07-1.21],0.0001162368516649
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22690,1419,1.21 [1.08-1.35],0.0009958389551011
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22885,129,1.18 [0.81-1.70],0.3887934396171001
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20170,1292,1.21 [1.08-1.37],0.0015772251018683
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19467,1576,1.26 [1.14-1.41],1.6913094045913003e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,18966,339,1.25 [0.99-1.58],0.0602901960081197
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14936,2734,1.05 [0.97-1.14],0.2583255529116576
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18892,488,1.39 [1.15-1.68],0.000757759028366
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22960,1689,1.20 [1.08-1.33],0.0004504557627417
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Mycoses,23076,638,1.15 [0.98-1.36],0.0923629728983124
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22193,1234,1.05 [0.93-1.18],0.4401228942062094
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23007,1425,1.15 [1.03-1.28],0.016136041389442
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21523,252,1.26 [0.97-1.64],0.0890937193204897
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23136,65,1.67 [1.00-2.80],0.0499420474600074
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22827,1245,1.18 [1.05-1.33],0.006382722937339
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22838,82,1.19 [0.76-1.88],0.4492215328599066
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23072,144,1.14 [0.80-1.61],0.4628921897023648
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23049,121,1.16 [0.79-1.70],0.4420779315577358
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21455,496,1.21 [1.00-1.47],0.0447584473106122
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21261,302,1.25 [0.98-1.59],0.0727247186457112
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21409,138,1.38 [0.97-1.96],0.0741383205622299
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23122,52,1.94 [1.12-3.36],0.0185994463332127
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23066,171,1.02 [0.74-1.42],0.898134439648738
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral warts,22950,55,1.20 [0.67-2.13],0.5361030137966407
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],22973,78,1.19 [0.74-1.91],0.4768311763750577
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm,22846,263,0.76 [0.59-1.00],0.0461455441169683
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23055,40,0.91 [0.46-1.80],0.7943959106899087
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23037,42,0.75 [0.39-1.44],0.3834775256971607
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11016,83,0.82 [0.51-1.32],0.4215207278423395
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22665,1674,0.89 [0.80-0.99],0.0260258753943297
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of meninges,23120,64,0.83 [0.48-1.43],0.5074374463055131
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23041,79,1.24 [0.77-1.99],0.381162789362876
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23110,121,1.37 [0.94-1.98],0.0978991173748938
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of ovary,12049,78,1.13 [0.70-1.82],0.6277823767764592
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23096,440,0.87 [0.71-1.07],0.176405333268512
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Caecum,23101,382,0.75 [0.60-0.93],0.0098204767686274
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22986,88,0.97 [0.62-1.52],0.8960884259824531
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Descending colon,23092,251,0.62 [0.47-0.82],0.0006740844700764
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Rectum,23050,405,1.03 [0.84-1.28],0.752682879046118
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22980,678,0.88 [0.74-1.03],0.1164940734744246
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23078,539,0.80 [0.67-0.96],0.0185943563437673
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Carcinoma in situ of breast,9049,50,1.31 [0.72-2.39],0.3758788084918621
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9091,65,1.81 [1.09-3.03],0.0228730214533361
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16495,71,1.10 [0.66-1.84],0.7214405764100575
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16522,98,0.86 [0.56-1.34],0.5172043896992359
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23081,125,1.22 [0.83-1.78],0.309235086412828
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma, any site",23082,123,1.23 [0.84-1.81],0.2887694841747272
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Leiomyoma of uterus,11778,168,1.14 [0.82-1.58],0.4344952111915118
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Lung cancer and mesothelioma,14645,476,0.60 [0.49-0.73],6.651662785450078e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Lymphoid leukaemia,16496,72,0.95 [0.57-1.60],0.8601042436855802
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16649,225,1.11 [0.83-1.49],0.4637347080485324
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16737,313,0.92 [0.72-1.18],0.5168822445581178
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9174,105,1.29 [0.85-1.95],0.2314559890509736
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16537,113,1.22 [0.81-1.82],0.3349826079245357
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16568,144,1.13 [0.79-1.61],0.5117233707751363
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16547,123,1.05 [0.71-1.55],0.801994155744645
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9157,88,1.45 [0.93-2.27],0.0989445834739435
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16552,128,0.89 [0.60-1.30],0.5378156870425093
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8326,971,1.01 [0.88-1.16],0.8486706357933081
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16558,134,0.61 [0.42-0.90],0.0121032560591379
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16516,92,0.86 [0.55-1.34],0.4971335319527339
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16571,147,1.35 [0.94-1.93],0.1046978182277997
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi,22987,185,1.07 [0.78-1.47],0.6632408629357538
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi of trunk,23107,79,0.71 [0.43-1.16],0.1669474013281123
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanoma in situ,16477,112,1.20 [0.79-1.80],0.3897979167736816
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16545,121,0.90 [0.61-1.34],0.6011667087445696
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16625,201,0.91 [0.67-1.23],0.5274582819063685
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16746,322,0.61 [0.48-0.78],5.569348067613562e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16553,129,0.91 [0.62-1.33],0.6133852985029088
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Other benign neoplasms of skin,22961,163,0.99 [0.71-1.38],0.9385351617109832
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17914,1490,1.05 [0.94-1.18],0.3625084303563871
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18000,1576,1.07 [0.96-1.19],0.2212227250805442
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22827,395,0.96 [0.78-1.19],0.7348646593247183
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20806,165,4.17 [3.18-5.47],7.5749132955587805e-25
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22505,73,1.38 [0.85-2.24],0.1909165022933585
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22365,3505,1.22 [1.14-1.32],3.737271963772773e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21411,72,1.34 [0.82-2.19],0.2497004636026505
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22663,65,0.85 [0.50-1.46],0.5644609687186909
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22614,1973,1.33 [1.21-1.47],2.7825339216051597e-09
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22612,1971,1.33 [1.21-1.47],2.4692394945829e-09
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20757,116,1.14 [0.76-1.70],0.5322842522440342
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22771,1432,1.28 [1.14-1.42],1.4620719122092746e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22713,115,1.11 [0.75-1.64],0.6144631545065666
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22506,74,0.72 [0.44-1.18],0.1956316324013036
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22508,76,1.21 [0.75-1.95],0.4453842488544569
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,22953,355,1.36 [1.09-1.70],0.0067447768299351
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23005,40,0.38 [0.19-0.76],0.0066771276065817
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22890,292,1.43 [1.12-1.82],0.0042968845332555
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21478,139,1.26 [0.88-1.80],0.2043301238032996
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15458,412,1.51 [1.22-1.86],0.0001267544017737
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21629,102,0.59 [0.39-0.90],0.0154284910090693
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21639,112,0.37 [0.25-0.56],2.711113137848678e-06
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15114,68,0.67 [0.39-1.16],0.1521072576320791
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21489,64,0.76 [0.44-1.29],0.3095300411679332
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20697,317,1.08 [0.85-1.38],0.5080490934616225
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22340,952,0.97 [0.85-1.12],0.6825676137300085
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21872,484,0.82 [0.68-1.00],0.0538373258582671
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21604,216,0.77 [0.58-1.04],0.0871667094149643
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22849,1424,0.91 [0.81-1.02],0.1039523580365552
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19477,1380,0.90 [0.80-1.01],0.0652479750108144
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15140,94,1.45 [0.93-2.27],0.098769308529289
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20848,101,1.45 [0.95-2.20],0.0857120252089821
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15415,369,1.13 [0.90-1.42],0.2851381678195032
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15102,56,0.98 [0.54-1.77],0.940648314469625
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19645,4599,0.98 [0.92-1.05],0.5936875663064083
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15314,268,1.40 [1.08-1.82],0.0118850536147302
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15762,716,1.20 [1.02-1.41],0.0250097330504222
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23075,372,1.62 [1.31-2.00],9.28281403857033e-06
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22865,162,2.68 [1.99-3.61],8.587169236224954e-11
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15200,154,0.96 [0.67-1.37],0.831915364703952
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15128,82,1.54 [0.96-2.48],0.0757987565507998
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22497,1750,1.15 [1.04-1.27],0.0085401628958035
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15433,387,2.36 [1.92-2.91],4.298185538554349e-16
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15472,426,2.31 [1.90-2.80],4.241733334314441e-17
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15910,864,0.94 [0.81-1.09],0.4412963091692179
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15223,177,1.11 [0.80-1.54],0.5317357004385208
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22855,152,2.76 [2.03-3.75],9.948117586003155e-11
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15945,899,1.11 [0.96-1.28],0.1773743532634722
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15705,659,0.90 [0.75-1.06],0.2064731808522677
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20459,79,1.52 [0.95-2.44],0.0787710698285266
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21485,6439,1.01 [0.95-1.06],0.8240263098696284
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20808,61,1.20 [0.70-2.04],0.5098341748509401
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20796,49,1.36 [0.74-2.52],0.3217939246611937
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22950,1908,0.93 [0.84-1.02],0.1365232324235854
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22948,1906,0.93 [0.84-1.02],0.1203701881119384
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20811,64,1.32 [0.78-2.22],0.3052973081263934
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22780,1126,0.97 [0.85-1.10],0.646607989457546
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17287,2241,1.20 [1.09-1.31],0.000101405539888
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23121,312,1.64 [1.31-2.05],1.5941217064234407e-05
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21518,130,1.16 [0.80-1.67],0.4347578774608616
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21773,119,0.98 [0.66-1.46],0.9362334442359506
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21819,165,0.97 [0.70-1.36],0.8687584969991589
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15247,201,0.91 [0.66-1.24],0.5365657417518795
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20341,187,1.28 [0.95-1.73],0.1080685121285564
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2479,99,1.46 [0.98-2.18],0.0626803161842349
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2646,307,1.17 [0.93-1.48],0.1721506022709398
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20238,84,1.42 [0.92-2.20],0.1133803550338626
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2453,76,4.03 [2.64-6.15],9.696999516325916e-11
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22291,2137,0.91 [0.83-1.00],0.0435339037085901
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22020,632,0.89 [0.75-1.06],0.1979832995454004
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20832,452,1.07 [0.88-1.31],0.5001207790638296
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16162,1116,1.12 [0.98-1.27],0.095394707905678
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22999,304,1.07 [0.84-1.37],0.5608626247132555
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21629,270,0.94 [0.72-1.22],0.6447638329927848
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Angina pectoris,19977,1573,1.09 [0.98-1.21],0.1197002985574298
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21735,376,1.03 [0.83-1.29],0.7827070615107955
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21447,88,1.10 [0.70-1.74],0.6728545862104109
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21654,295,1.19 [0.93-1.53],0.167152838820058
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11715,2849,1.12 [1.03-1.21],0.0087067322650141
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,AV-block,17561,680,1.22 [1.03-1.44],0.0188306063152512
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23050,580,1.33 [1.12-1.59],0.0011248576707861
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiac arrest,9129,263,1.92 [1.46-2.52],2.392052585698243e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17086,205,1.58 [1.17-2.13],0.0027739967124998
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16990,109,1.72 [1.15-2.57],0.0083056312201536
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23130,81,1.40 [0.89-2.21],0.1488148582731326
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Conduction disorders,18449,1568,1.26 [1.13-1.41],2.511458687010385e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21136,2756,1.15 [1.06-1.25],0.000698304218149
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18569,8906,0.96 [0.92-1.01],0.0887181075283481
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21555,334,1.13 [0.90-1.43],0.2952898528185107
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Endocarditis,16983,102,1.56 [1.02-2.40],0.0396054423380445
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22847,1668,1.28 [1.15-1.41],3.5071046997523025e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertension,19810,7930,0.95 [0.90-1.00],0.0482915776939768
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19829,7949,0.96 [0.91-1.01],0.0861244249180827
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22961,99,1.31 [0.86-1.98],0.2045530878045167
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12141,261,2.34 [1.82-3.01],2.758313864519132e-11
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12089,209,5.98 [4.57-7.82],6.52301254685889e-39
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypotension,22950,1656,1.26 [1.13-1.39],1.336138320440376e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21841,147,1.03 [0.72-1.47],0.8681267461540886
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21312,2908,1.12 [1.04-1.21],0.0042278620816368
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22620,801,1.15 [0.99-1.33],0.0689704023374258
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17406,525,1.47 [1.22-1.78],4.673830094831046e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22445,1059,1.00 [0.88-1.14],0.9830641859406066
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19317,913,1.09 [0.94-1.25],0.2494104760684775
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23005,190,1.06 [0.78-1.44],0.6971321879209401
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23092,406,1.05 [0.85-1.30],0.6364230777232791
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Oesophageal varices,21290,69,1.40 [0.85-2.30],0.1819288940728327
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other aneurysm,21465,106,1.06 [0.70-1.62],0.7703243389630912
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arrhythmias,17477,596,1.27 [1.07-1.52],0.0076899885600074
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21496,137,1.14 [0.79-1.65],0.483277883622155
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21694,335,1.30 [1.03-1.64],0.0271432055317797
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17103,222,1.22 [0.91-1.64],0.178326572640478
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other disorders of veins,21341,120,1.23 [0.85-1.80],0.2742822211345493
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21269,48,1.13 [0.62-2.07],0.6947776183507494
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21074,90,1.36 [0.88-2.11],0.1624927114834132
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21402,181,1.21 [0.89-1.66],0.2255991620072639
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18352,1471,1.29 [1.15-1.44],9.353977379767431e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21355,61,1.58 [0.93-2.66],0.0877397822525467
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22090,731,1.15 [0.98-1.34],0.08651963436842
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22367,528,1.45 [1.22-1.74],3.349369136725698e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",21961,977,1.03 [0.90-1.18],0.6450011675165284
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9281,415,1.50 [1.21-1.87],0.0002681572431086
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21921,597,1.28 [1.08-1.52],0.0050649712073476
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21644,423,1.15 [0.93-1.41],0.1940223037921248
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22434,595,1.06 [0.89-1.26],0.5409025060806152
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23036,972,1.31 [1.14-1.50],8.581455353082601e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17403,522,1.35 [1.12-1.63],0.0019543990080771
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22361,522,1.42 [1.19-1.70],0.0001227189379746
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21253,269,1.47 [1.15-1.89],0.0024526221917317
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22604,910,1.12 [0.97-1.29],0.1200504075358581
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22589,951,1.09 [0.95-1.25],0.2068041125580658
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21808,63,0.70 [0.40-1.21],0.2015901189399168
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21466,107,1.68 [1.11-2.56],0.0141952307634657
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22144,325,1.20 [0.95-1.52],0.1243643119040709
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21718,332,0.92 [0.73-1.17],0.5049222986681661
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Varicose veins,21740,519,1.21 [1.00-1.45],0.0490770356869586
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21381,121,0.96 [0.64-1.42],0.8305371610338265
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22858,941,1.09 [0.95-1.26],0.1980177639366546
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23052,331,0.53 [0.42-0.67],8.772099459033466e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19767,1375,0.94 [0.83-1.05],0.2836098132359446
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Any mental disorder,22601,4209,0.89 [0.83-0.95],0.0003432107869364
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23023,390,0.53 [0.42-0.65],7.129214232946766e-09
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19844,1452,0.88 [0.79-0.99],0.0325455341554895
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18479,87,0.67 [0.42-1.07],0.0927502196300269
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Smoking dependency,22621,1179,0.85 [0.75-0.96],0.0089405027873379
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19841,1449,0.80 [0.71-0.89],6.415340428506575e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Vascular dementia,22232,228,0.98 [0.74-1.30],0.9069625787810788
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Alzheimer disease,23132,591,0.86 [0.72-1.02],0.0831240259028125
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",14169,112,1.18 [0.78-1.77],0.4368891690245922
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Bell's palsy,21280,84,1.14 [0.72-1.80],0.589137955659689
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21690,494,0.80 [0.66-0.97],0.0216022816300066
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral cysts,22677,250,1.46 [1.12-1.90],0.0049311987876439
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23058,413,1.32 [1.08-1.61],0.007693185666536
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22285,76,0.83 [0.51-1.37],0.4707909824940369
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23116,69,0.60 [0.35-1.00],0.051320246323713
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22514,87,1.29 [0.82-2.02],0.2764644843749432
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Epilepsy,21619,308,0.86 [0.67-1.10],0.2156107567461561
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22671,1360,1.08 [0.96-1.21],0.1891758510189795
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23078,920,0.87 [0.76-1.00],0.0554793145049171
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22471,3447,1.02 [0.95-1.10],0.5222283214400261
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Generalized epilepsy,22749,54,0.58 [0.32-1.05],0.071765016182492
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hemiplegia,22984,339,1.51 [1.21-1.89],0.000242686498993
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hydrocephalus,22501,74,0.68 [0.41-1.13],0.1366016720446217
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23119,73,1.42 [0.87-2.32],0.161495748727865
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21262,66,0.73 [0.43-1.25],0.2544075569646314
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21270,74,0.63 [0.38-1.04],0.0686205751519872
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Memory loss,21983,141,0.80 [0.56-1.16],0.2379043747381075
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Migraine,21593,282,1.59 [1.24-2.03],0.0002477921599529
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23085,258,1.61 [1.24-2.08],0.0002978626849396
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Motor neuron disease,14255,174,1.00 [0.72-1.40],0.994305520406519
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23001,62,1.49 [0.88-2.52],0.1364138632322713
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22421,1225,0.90 [0.80-1.02],0.1044752930384734
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Neurological diseases,21643,4363,1.04 [0.97-1.11],0.2489112917957368
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22528,319,0.93 [0.73-1.18],0.5297618410596578
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21619,423,0.94 [0.77-1.16],0.5818852599480167
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23056,350,1.67 [1.34-2.07],3.7590268647306815e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17291,974,0.94 [0.82-1.08],0.3594379985262784
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22515,88,0.81 [0.51-1.27],0.3542467936599868
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22589,162,1.18 [0.85-1.64],0.3171842069103984
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22391,233,0.94 [0.71-1.25],0.6891549510764229
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21290,94,1.30 [0.84-2.00],0.2399590047824783
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other headache syndromes,21364,53,0.79 [0.44-1.43],0.4416433885983318
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other neurological diseases,23016,589,1.15 [0.96-1.36],0.1259123086282154
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other sleep disorders,21829,518,0.99 [0.82-1.19],0.9048592979556532
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Parkinson's disease,23099,683,0.84 [0.71-0.99],0.0406692632119582
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22474,47,2.44 [1.37-4.33],0.0023913395878442
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Restless leg syndrome,23133,104,0.97 [0.63-1.48],0.8834007901557434
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Sleep apnoea,22903,440,1.01 [0.82-1.23],0.9607069712456884
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22768,62,1.73 [1.02-2.93],0.0410094648649437
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23121,203,1.14 [0.85-1.54],0.384701731754935
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21265,69,1.51 [0.92-2.47],0.1039780730005176
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23132,597,0.84 [0.71-1.00],0.0560441851784324
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22170,222,1.02 [0.76-1.35],0.9132534533211488
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22486,157,1.24 [0.88-1.74],0.2114263168196054
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22671,565,0.98 [0.82-1.18],0.8435436228434098
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22879,266,1.09 [0.85-1.40],0.5088355666548348
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21899,68,0.72 [0.42-1.21],0.2149354188464092
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21868,37,1.60 [0.81-3.17],0.1769480492620575
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23010,74,1.12 [0.69-1.83],0.6468884052165546
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22816,226,1.09 [0.82-1.45],0.5601173956642685
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2457,77,3.56 [2.34-5.43],3.459117175461265e-09
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3027,112,1.48 [1.02-2.14],0.0370249869126102
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22439,110,0.82 [0.54-1.24],0.3414684779634122
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22834,1429,0.91 [0.81-1.02],0.0935574832235755
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22716,885,0.83 [0.72-0.96],0.0138454135051502
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22133,302,0.94 [0.73-1.20],0.608029717399787
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23057,951,1.07 [0.93-1.23],0.3637180441057464
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23126,80,0.79 [0.49-1.28],0.3321300970123204
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,22984,878,1.06 [0.92-1.23],0.4265954394098807
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23089,499,1.00 [0.83-1.22],0.97028479047201
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23011,229,1.00 [0.76-1.33],0.9729599489217672
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,21933,102,0.65 [0.42-0.99],0.0468282087342549
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,21937,106,0.89 [0.59-1.36],0.5990264718811724
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21906,75,0.80 [0.49-1.31],0.3691636533193729
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22996,1009,0.94 [0.82-1.07],0.356623838795845
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22255,268,0.95 [0.73-1.24],0.725946310890446
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22178,72,0.86 [0.52-1.42],0.5466274625990816
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22715,125,0.83 [0.56-1.21],0.3270046307550364
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,22978,388,1.08 [0.87-1.34],0.4790389305112098
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22328,222,1.29 [0.97-1.71],0.079884397013707
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22927,145,1.15 [0.81-1.64],0.4330819202898081
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22663,676,1.01 [0.86-1.19],0.9253552330360824
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22489,160,1.06 [0.76-1.48],0.7378802923817669
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20668,3239,0.97 [0.90-1.04],0.3955390309929711
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,22933,343,1.09 [0.86-1.37],0.4773397182330748
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23118,188,1.12 [0.82-1.52],0.4828259865144515
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22375,544,0.76 [0.63-0.91],0.0034085835833662
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22681,91,0.80 [0.51-1.25],0.3274209360791118
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23118,72,0.72 [0.43-1.20],0.2049867657852666
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,21959,128,1.10 [0.76-1.60],0.6207609490635492
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22005,174,0.63 [0.46-0.88],0.0065675596206588
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21568,163,0.99 [0.71-1.38],0.9431091157047068
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22169,63,1.26 [0.74-2.15],0.394775735510499
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21479,74,0.65 [0.39-1.08],0.0977809785344537
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22099,112,0.89 [0.59-1.33],0.554572185911093
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22281,294,0.87 [0.67-1.11],0.2659800661922079
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,21991,160,0.90 [0.64-1.25],0.5213529091334183
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21502,97,0.97 [0.62-1.51],0.8885952734253184
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21537,132,0.66 [0.45-0.96],0.0316096208023416
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20175,2746,1.01 [0.93-1.10],0.7753587249701798
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21924,93,1.16 [0.75-1.79],0.514526316054983
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22842,513,1.01 [0.84-1.22],0.8991717253992263
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22410,81,0.94 [0.59-1.49],0.7782655264849216
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22534,205,1.12 [0.83-1.51],0.4462597696365706
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22910,113,0.84 [0.55-1.26],0.3872534803548033
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23087,140,1.12 [0.78-1.60],0.5339170962568794
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,22995,116,1.14 [0.77-1.69],0.5071078964670014
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22862,65,1.60 [0.95-2.68],0.0757276556326577
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,22867,70,0.96 [0.57-1.61],0.8779860221390683
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23027,1244,1.07 [0.94-1.20],0.3017305759551099
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22728,945,1.11 [0.96-1.27],0.1491135348860721
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21939,156,0.85 [0.60-1.20],0.3660637688867666
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21870,87,0.59 [0.37-0.94],0.0257430292422032
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute pharyngitis,22941,66,1.40 [0.84-2.33],0.1959828914044578
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23061,186,1.12 [0.82-1.52],0.4785057679473732
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22937,62,1.65 [0.98-2.76],0.0581997326207319
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,All influenza,20443,157,1.24 [0.88-1.75],0.216982648191217
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20440,154,1.27 [0.90-1.79],0.1787213535355253
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14273,104,0.75 [0.48-1.17],0.212296137604618
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Allergic rhinitis,23023,235,0.95 [0.72-1.26],0.7445594352113112
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15477,1702,0.83 [0.74-0.92],0.0005165709412924
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15848,1679,0.83 [0.74-0.92],0.0007433080850843
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22619,178,1.35 [0.99-1.84],0.0578382031841107
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20390,104,1.42 [0.94-2.13],0.0960681201950535
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Bronchiectasis,19404,514,0.64 [0.53-0.78],9.496353801700948e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18960,70,1.00 [0.60-1.68],0.9910466799411796
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22003,3113,0.76 [0.71-0.82],8.332883917142332e-12
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21911,72,0.87 [0.52-1.46],0.6000311178153339
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic sinusitis,21973,134,0.67 [0.46-0.98],0.0364975347767069
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22841,1627,0.60 [0.54-0.67],7.486447866924723e-21
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Deviated nasal septum,21921,82,1.16 [0.73-1.85],0.5339874530009237
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20980,6089,0.93 [0.88-0.98],0.0069038826996105
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22179,340,0.89 [0.71-1.13],0.3455983430783033
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Early onset COPD,21321,107,0.53 [0.35-0.81],0.0033857473161163
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Emphysema,19326,436,0.49 [0.40-0.60],1.5078264718806043e-11
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21828,450,0.51 [0.42-0.63],1.5925727109039343e-10
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22874,2588,1.00 [0.92-1.08],0.9406467923729372
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Interstitial lung disease,21872,494,0.58 [0.48-0.71],4.770842882426772e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Later onset COPD,22612,1520,0.60 [0.54-0.67],2.6255438256383933e-19
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23117,499,1.18 [0.98-1.42],0.0876714112022884
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Nasal polyp,21937,98,1.15 [0.75-1.76],0.5139166168910443
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22848,1297,1.09 [0.97-1.22],0.1566330331538442
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of pleura,22844,2680,1.02 [0.94-1.10],0.6915191680431798
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22590,751,0.84 [0.72-0.98],0.0258761467744917
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other pleural conditions,20232,68,0.75 [0.44-1.28],0.2987529065764861
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23013,590,0.72 [0.60-0.86],0.0002485358705355
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23005,1704,0.91 [0.82-1.01],0.0663473882671332
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural effusion,21533,1369,1.20 [1.07-1.34],0.0019825556951047
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural plaque,20418,254,1.01 [0.77-1.32],0.9611026625006932
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22590,2304,0.98 [0.89-1.07],0.5885511583767569
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23006,388,1.19 [0.97-1.48],0.1023028040096966
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pneumothorax,20331,167,1.07 [0.77-1.49],0.6855515713310351
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pollen allergy,23121,200,0.95 [0.70-1.29],0.7619663123326859
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pulmonary oedema,22516,93,1.97 [1.32-2.93],0.0008173062149297
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14240,71,0.72 [0.43-1.23],0.2328410432784222
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22824,1273,1.08 [0.96-1.22],0.1947790543784144
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22075,236,0.94 [0.71-1.25],0.6684453740161866
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Viral pneumonia,20585,299,1.40 [1.09-1.78],0.0072040267406252
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22629,237,1.37 [1.05-1.80],0.0217998111613122
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7379,121,0.66 [0.44-0.99],0.0443531369553446
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14647,61,1.08 [0.63-1.86],0.782432776312689
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute appendicitis,23016,126,0.81 [0.55-1.18],0.2728404525130992
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute gastritis,16065,104,1.61 [1.06-2.43],0.0248429402777884
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute pancreatitis,21083,197,1.40 [1.04-1.88],0.0268686861964916
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute peritonitis,22639,113,1.92 [1.32-2.79],0.0006717089478069
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22145,63,0.85 [0.49-1.45],0.54434743271278
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Barrett oesophagus,16468,507,1.16 [0.96-1.41],0.1261815329155855
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21029,143,1.49 [1.05-2.12],0.0255697530384918
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22711,143,1.46 [1.03-2.06],0.0328442493647937
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholecystitis,21107,221,1.26 [0.95-1.67],0.1053243721716149
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholelithiasis,21941,1055,1.26 [1.11-1.44],0.0004697079371369
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic gastritis,16307,346,1.32 [1.05-1.65],0.0179627215109009
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic pancreatitis,20941,55,0.77 [0.43-1.37],0.3697942690668147
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22991,129,1.48 [1.03-2.13],0.0333272120839947
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Coeliac disease,21394,128,1.08 [0.74-1.58],0.6833589865523882
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Collagenous colitis,21377,98,1.25 [0.81-1.92],0.3087954216549053
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23015,159,0.99 [0.71-1.39],0.9681080640138994
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Constipation,22846,2127,0.99 [0.90-1.08],0.8134626907466862
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn disease,21367,88,1.21 [0.77-1.90],0.3983220668466795
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22781,68,1.08 [0.65-1.80],0.7641816166082757
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21360,81,1.54 [0.98-2.43],0.0634102926886965
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Dental caries,22516,190,1.09 [0.80-1.47],0.6004704156756255
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19984,2562,1.08 [0.99-1.18],0.0675541394073317
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of appendix,23047,157,0.80 [0.56-1.13],0.1992649941761913
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of liver,23013,931,1.05 [0.92-1.21],0.4679116248258975
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20564,4603,1.07 [1.01-1.14],0.0284539151002757
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22801,475,1.28 [1.06-1.55],0.0108964474820529
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23040,514,1.26 [1.04-1.52],0.0154318868653347
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22421,95,1.63 [1.07-2.49],0.0231516854112916
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22290,60,1.01 [0.58-1.74],0.9838712755879764
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22797,1531,1.08 [0.97-1.20],0.1790274864236322
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of tongue,22309,95,0.82 [0.52-1.27],0.3726253879931082
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22412,1526,1.22 [1.10-1.36],0.0002841927876232
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18366,3780,0.94 [0.87-1.01],0.070162235976564
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Duodenal ulcer,16212,251,1.06 [0.81-1.39],0.6777500476170416
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23037,204,0.96 [0.72-1.29],0.7995916290776661
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23096,26,1.02 [0.43-2.37],0.970646112881506
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22233,151,1.48 [1.06-2.07],0.0203729122561895
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14694,108,1.29 [0.86-1.92],0.2161950249921198
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Functional dyspepsia,16524,563,0.93 [0.78-1.12],0.4432729662198195
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastric ulcer,16390,429,1.35 [1.10-1.65],0.0034361189616544
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18630,2669,0.96 [0.88-1.04],0.316350604524773
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16617,656,1.19 [1.01-1.40],0.0402659878192085
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16675,8222,1.01 [0.96-1.06],0.6847823814878834
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,GI-bleeding,22537,1271,1.10 [0.98-1.24],0.1062321100075219
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22372,46,0.93 [0.49-1.74],0.8103058285018194
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15580,1181,1.02 [0.90-1.16],0.7291255651199726
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22152,70,0.92 [0.55-1.53],0.7447850543999768
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Hernia,21068,3646,1.01 [0.94-1.09],0.7336126379366048
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impacted teeth,23100,24,0.87 [0.36-2.12],0.7593356449672689
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impaction of intestines,14662,76,1.38 [0.85-2.24],0.1949942618751179
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Inguinal hernia,18519,1097,0.89 [0.78-1.02],0.0942640723792426
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17545,123,0.67 [0.45-1.00],0.0479718687381265
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14701,115,1.13 [0.76-1.68],0.5440106443259844
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21413,147,1.08 [0.75-1.54],0.6839289559060794
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15101,515,1.16 [0.96-1.41],0.1161828100110326
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23101,341,0.93 [0.74-1.17],0.5303401176277243
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22068,789,1.23 [1.06-1.43],0.0059174882467116
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22369,1090,1.20 [1.06-1.37],0.0041263570630474
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16182,221,0.85 [0.63-1.14],0.2702137459097432
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophagitis,16663,702,1.20 [1.02-1.40],0.0290611669238034
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23079,136,0.97 [0.68-1.40],0.8773515106413535
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17505,83,1.22 [0.76-1.94],0.408812842718795
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15964,1378,0.95 [0.85-1.07],0.4196921079997452
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21248,362,1.16 [0.92-1.45],0.203261876965227
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21033,147,1.02 [0.72-1.45],0.9127208837911412
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestine,16527,1941,0.99 [0.90-1.09],0.892046793965923
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestines,20800,6214,1.00 [0.95-1.06],0.9410080958994168
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22271,211,0.96 [0.72-1.29],0.782951969870696
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of liver,22852,770,1.08 [0.93-1.26],0.3261452418394008
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16726,765,1.20 [1.03-1.40],0.0211068674477823
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21102,216,1.44 [1.08-1.91],0.0120234212565556
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22960,434,1.18 [0.96-1.45],0.113083484820526
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17056,1095,1.18 [1.04-1.35],0.0119092269225726
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22554,1288,1.09 [0.97-1.22],0.1676989948033428
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22507,181,1.40 [1.03-1.91],0.0302931845608868
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16759,2173,0.97 [0.89-1.07],0.5856190432979618
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18140,2179,1.11 [1.02-1.22],0.0213550158774671
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22197,115,1.34 [0.91-1.98],0.1345972275627366
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22239,960,1.22 [1.07-1.40],0.0032958124386528
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15034,448,1.15 [0.94-1.40],0.1822977993641738
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23092,30,1.24 [0.57-2.72],0.5822691391799903
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15204,618,1.06 [0.89-1.26],0.5186333586685823
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21423,157,1.25 [0.89-1.76],0.1905236557816492
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23121,53,1.11 [0.62-1.97],0.7314664008010088
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22320,103,0.95 [0.62-1.44],0.7988932446480196
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Toxic colitis,21359,80,1.40 [0.88-2.24],0.1580002889430251
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16307,346,1.04 [0.83-1.31],0.7133821117250612
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcerative colitis,21446,167,1.03 [0.74-1.43],0.8669062454058503
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21412,133,0.86 [0.59-1.25],0.436021063926038
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Umbilical hernia,17672,250,0.78 [0.60-1.02],0.0736459467905766
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14833,247,1.35 [1.03-1.76],0.0294325056161829
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ventral hernia,17712,290,0.79 [0.61-1.02],0.0653655047702302
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Volvulus,14681,95,0.66 [0.42-1.03],0.0702309870935183
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23027,429,1.26 [1.03-1.55],0.0270893903666648
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22775,64,1.08 [0.63-1.82],0.7879338424420737
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20574,169,1.12 [0.80-1.56],0.5090567998433233
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22502,832,1.19 [1.03-1.38],0.0169142318720091
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21812,142,1.31 [0.92-1.86],0.1364274188711708
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21035,630,1.26 [1.06-1.48],0.007263990239499
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22789,318,1.03 [0.81-1.31],0.7970263537075677
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23031,560,1.28 [1.07-1.53],0.0066879358863848
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22517,46,1.62 [0.88-2.98],0.1219292153013466
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21532,3727,1.09 [1.02-1.17],0.0118150627486766
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22698,436,1.13 [0.92-1.38],0.230090472222502
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22566,304,1.13 [0.89-1.44],0.3282432728195726
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22751,1081,1.19 [1.05-1.35],0.0068976252990344
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23113,59,0.67 [0.38-1.19],0.172903318227348
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20462,57,0.68 [0.38-1.20],0.1793556315421208
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22324,62,1.20 [0.71-2.03],0.5007368244044095
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22776,305,1.02 [0.80-1.30],0.8695615332397407
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21009,604,0.83 [0.69-0.99],0.0387541747187291
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20497,92,1.32 [0.84-2.06],0.2255599825662879
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23044,96,2.00 [1.34-2.98],0.0007146417235632
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21909,239,1.33 [1.01-1.74],0.0394349339789029
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22932,221,0.74 [0.55-0.98],0.0380151914998997
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22568,97,1.85 [1.23-2.79],0.0031723497718758
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20484,79,1.16 [0.71-1.87],0.5561078463418895
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22520,2115,1.09 [1.00-1.20],0.0600401508364258
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21053,648,0.88 [0.74-1.04],0.1273155933938934
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20501,96,1.33 [0.86-2.06],0.1952188583877727
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23041,330,0.79 [0.62-1.00],0.0543638110641745
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22547,76,1.82 [1.14-2.91],0.0118299969301638
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22981,270,0.79 [0.61-1.03],0.0765565215401309
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23059,461,1.21 [0.99-1.48],0.0601223882489165
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20531,126,0.95 [0.64-1.40],0.7870430824267822
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20747,342,1.09 [0.86-1.37],0.4882823735897932
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23047,449,1.24 [1.01-1.51],0.0382475646991013
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20745,340,1.45 [1.16-1.80],0.0010630678665494
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23106,158,1.79 [1.30-2.46],0.0003870510714577
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19293,82,0.84 [0.53-1.35],0.4786612906101612
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20376,6450,0.97 [0.92-1.02],0.2094514879445605
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18964,5038,0.95 [0.89-1.01],0.1012415931568532
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19265,54,0.88 [0.49-1.57],0.6695761766751533
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19197,146,1.14 [0.81-1.62],0.4559323480625786
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19241,190,1.42 [1.05-1.92],0.0226246376127476
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22870,66,0.92 [0.54-1.55],0.747587558680628
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19204,153,0.99 [0.70-1.41],0.9633956232022372
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15414,1488,1.01 [0.91-1.14],0.7982197825050323
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22922,241,1.10 [0.84-1.45],0.4731843476651843
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19640,589,0.84 [0.70-1.00],0.0537149020516916
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18716,8035,0.95 [0.90-0.99],0.023155611640295
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20582,122,0.75 [0.51-1.11],0.1515864005862296
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19395,184,1.13 [0.83-1.54],0.4502523617866411
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19713,502,0.90 [0.75-1.09],0.3004228286051849
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22200,3149,0.97 [0.90-1.05],0.5141970378604084
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19523,312,0.91 [0.71-1.16],0.4378570008401234
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19360,149,0.90 [0.63-1.28],0.5622514604633788
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19323,112,0.90 [0.60-1.35],0.614379667341678
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22381,102,0.93 [0.61-1.43],0.7558510024147769
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15939,2013,0.91 [0.82-1.00],0.0475848843192613
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14726,800,1.37 [1.18-1.59],3.2315820521677524e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23035,793,1.36 [1.18-1.58],3.906067174794605e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14003,77,0.52 [0.31-0.87],0.0122291951520874
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14228,302,0.84 [0.65-1.09],0.1835210420467152
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19477,266,0.80 [0.61-1.04],0.0967475643942239
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14404,478,0.87 [0.72-1.07],0.188264240971079
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19131,80,1.14 [0.70-1.83],0.5990808746634277
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19739,688,0.95 [0.81-1.12],0.573976662410178
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19364,313,0.98 [0.77-1.25],0.8917667114260135
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14372,446,0.87 [0.71-1.07],0.1973468058527026
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19282,71,1.12 [0.67-1.86],0.662038494594564
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19271,60,2.10 [1.25-3.52],0.0051615610298876
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20545,85,0.87 [0.55-1.39],0.5716932557534131
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22696,2236,0.89 [0.81-0.97],0.0122610827190178
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22032,1572,0.91 [0.81-1.01],0.0729547812354544
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22960,543,0.92 [0.77-1.10],0.3750827499121087
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17076,3150,0.93 [0.87-1.01],0.0881280929103459
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,13968,42,0.65 [0.33-1.29],0.2180872851498062
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19315,104,0.73 [0.48-1.12],0.1458633718493262
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,13997,71,1.83 [1.11-3.01],0.017102812206816
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14064,138,0.77 [0.53-1.12],0.1697974526143582
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20704,244,0.96 [0.73-1.26],0.7547337493314987
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,20966,506,0.92 [0.76-1.11],0.3836593314213745
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23109,114,1.25 [0.84-1.86],0.2778620523245816
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21038,1987,1.01 [0.92-1.12],0.7675141390505681
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19287,76,1.23 [0.75-2.00],0.4108002785991433
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14080,154,0.90 [0.63-1.28],0.5559909046822737
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19840,789,1.01 [0.87-1.17],0.9171140200906358
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16115,2189,0.96 [0.87-1.05],0.3771686756603655
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22408,129,1.01 [0.69-1.47],0.973252994753826
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23121,62,1.02 [0.59-1.74],0.9548703571283598
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19289,78,0.60 [0.37-0.98],0.0422449051625504
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20564,1353,1.07 [0.96-1.20],0.2385558906394067
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19321,110,1.29 [0.86-1.93],0.21411327672637
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15992,2066,1.00 [0.91-1.10],0.979795391394577
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20577,117,0.98 [0.66-1.46],0.9106220391086324
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19248,37,0.68 [0.32-1.41],0.2985802045182452
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19250,199,1.24 [0.92-1.68],0.1549153903460229
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19899,688,1.02 [0.87-1.20],0.7939509743252627
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22769,490,0.87 [0.71-1.05],0.1535964877550204
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19708,657,1.10 [0.93-1.30],0.252235407466345
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22975,537,0.91 [0.76-1.10],0.3266085510203194
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23107,70,1.14 [0.69-1.88],0.6097216243996113
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19377,166,1.09 [0.78-1.51],0.6241347248683125
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17994,894,1.11 [0.96-1.28],0.1422267874330607
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19852,641,1.14 [0.97-1.35],0.110859822506446
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19491,280,0.89 [0.69-1.16],0.3882009352538336
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",13997,71,1.33 [0.80-2.22],0.2697963481060306
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17049,3123,1.05 [0.97-1.13],0.2276208772136844
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14771,845,0.87 [0.75-1.02],0.0820518124961158
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22652,373,0.90 [0.72-1.13],0.3847380361110024
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23076,81,1.28 [0.79-2.05],0.3134637898394381
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20467,72,0.94 [0.58-1.53],0.7993015533627552
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,13989,63,1.01 [0.59-1.74],0.9735632322673032
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19157,106,0.79 [0.52-1.20],0.2678461776494088
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14476,550,0.93 [0.77-1.11],0.4190781472429576
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19551,340,0.92 [0.73-1.16],0.4679313961795794
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19338,287,0.95 [0.74-1.23],0.7082312843360614
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19318,267,0.82 [0.63-1.07],0.1389618837358154
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16246,68,0.76 [0.45-1.29],0.3101473211191086
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23111,74,1.15 [0.71-1.88],0.5662185861703686
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19768,557,0.84 [0.70-1.00],0.0561854125237114
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22374,95,0.75 [0.48-1.17],0.2004851489661374
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21848,2637,1.00 [0.92-1.09],0.999867851519494
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19357,146,0.78 [0.54-1.11],0.1705580493107651
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19774,723,0.93 [0.79-1.09],0.3568324443836999
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21760,278,1.11 [0.86-1.43],0.4243964059020512
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19311,260,0.83 [0.64-1.09],0.1879862039344535
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21065,2014,1.00 [0.91-1.10],0.9720756406556248
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20356,1305,1.03 [0.92-1.16],0.6087002574787228
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19272,61,0.84 [0.48-1.46],0.528236786146977
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22397,118,0.90 [0.61-1.33],0.6011852452691815
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19374,163,0.99 [0.71-1.39],0.962500404253057
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19300,89,0.79 [0.50-1.25],0.3166432917421298
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14001,75,1.40 [0.85-2.30],0.1823584752433193
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21607,2256,1.55 [1.41-1.69],7.502796792417212e-22
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9267,26,0.58 [0.24-1.40],0.2275884390804738
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11750,33,1.08 [0.51-2.29],0.8490752178313666
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22804,308,0.95 [0.75-1.21],0.6848325646181401
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22597,101,1.06 [0.69-1.62],0.8024865842009636
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21696,2345,2.69 [2.48-2.93],3.2493513330972533e-121
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22899,135,4.63 [3.60-5.97],1.739119620111354e-32
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22822,414,1.41 [1.15-1.74],0.0010539728708944
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cystitis,19269,299,1.19 [0.93-1.53],0.1647814360975238
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Dialysis,19449,98,10.48 [7.91-13.90],6.357306061522932e-60
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10187,2135,1.06 [0.97-1.16],0.2053363192653673
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11853,136,0.87 [0.60-1.26],0.4711600725499217
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Endometriosis,9281,40,0.69 [0.35-1.39],0.3011531089601998
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9823,582,0.73 [0.60-0.87],0.0005228483146979
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19046,6299,1.18 [1.12-1.25],1.573963435419877e-09
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22862,98,3.17 [2.22-4.53],2.2332565300317902e-10
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hydrocele,8169,117,1.28 [0.87-1.88],0.2173305777060579
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19419,351,1.08 [0.85-1.36],0.5475057712898255
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9877,1825,1.06 [0.96-1.17],0.279006364256999
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11921,158,0.89 [0.63-1.25],0.5077406347054992
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8176,124,1.14 [0.78-1.68],0.4886338223170774
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19056,86,1.24 [0.78-1.96],0.3588218336081736
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10271,1030,0.85 [0.74-0.97],0.0187264446338083
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8111,59,1.91 [1.13-3.21],0.0155354484274706
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9280,39,1.18 [0.61-2.29],0.6184921576737497
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23118,88,1.27 [0.81-1.99],0.2989449519441748
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23120,86,1.21 [0.77-1.89],0.4169098159116079
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21923,2953,1.12 [1.04-1.21],0.0040685805480634
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19913,943,1.09 [0.95-1.25],0.2419204160755522
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11769,52,0.62 [0.34-1.13],0.1224567451274842
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23044,636,1.69 [1.44-1.99],2.697544812507488e-10
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8203,151,1.49 [1.07-2.09],0.0194070493797816
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8209,157,1.16 [0.83-1.63],0.3786523001295246
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8203,151,1.30 [0.92-1.82],0.1358350185891795
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23093,87,1.72 [1.12-2.67],0.0142347473582887
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21319,2349,1.15 [1.05-1.25],0.0022303553359785
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11845,82,0.95 [0.59-1.53],0.8335321910122049
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9310,69,1.08 [0.65-1.81],0.7629865528364767
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9378,137,0.79 [0.55-1.14],0.2043464605682502
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9292,51,0.47 [0.25-0.88],0.0174364383797396
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9344,103,0.67 [0.43-1.03],0.0693110643625374
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19483,415,1.27 [1.02-1.57],0.0326004553940569
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22611,203,2.15 [1.63-2.84],6.114395112844756e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9366,125,1.14 [0.78-1.67],0.4969080917647037
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9266,25,0.43 [0.18-1.05],0.0630565293955432
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9450,209,1.02 [0.76-1.36],0.9103913559664514
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9334,93,0.63 [0.40-1.00],0.0490724202289736
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9451,210,1.11 [0.83-1.48],0.4949359982155
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22812,48,2.34 [1.36-4.04],0.0021433113378082
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8205,153,1.36 [0.97-1.91],0.0767874799831661
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22839,3771,1.70 [1.59-1.82],3.240944748556159e-51
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19162,94,1.17 [0.74-1.85],0.4894652867581188
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19533,182,3.35 [2.52-4.46],7.084693057719639e-17
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22537,41,1.24 [0.65-2.37],0.5098099111651485
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19239,269,1.32 [1.02-1.71],0.0341446644771498
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22891,395,0.96 [0.77-1.19],0.6930725877377252
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9278,37,1.21 [0.62-2.37],0.5790466224061547
